The Scientist

» Best Places to Work and disease/medicine

Most Recent

image: Setback for Malaria Vaccine

Setback for Malaria Vaccine

By | November 9, 2012

The malaria vaccine under development by GSK and the PATH initiative only protects about one in three babies, though some researchers say those odds are better than nothing.

0 Comments

image: Epigenetics Armed German E. coli

Epigenetics Armed German E. coli

By | November 9, 2012

The 2011 outbreak in Germany that caused some 50 deaths was caused by a strain of E. coli with a complex mechanism of gene regulation.

3 Comments

image: Rate Your Workplace Today!

Rate Your Workplace Today!

By | November 9, 2012

Only two weeks left to participate in The Scientist’s 2013 survey for best place to work in the life sciences.

0 Comments

image: How Mole Rats Fight Cancer

How Mole Rats Fight Cancer

By | November 6, 2012

Blind mole rats resist cancer by killing cells that proliferate in a similar way to tumor cells.

0 Comments

image: The Brain on Anesthetics

The Brain on Anesthetics

By | November 5, 2012

Recording brain activity as patients are anesthetized for surgery, researchers identify a pattern that may signal loss of consciousness.  

1 Comment

image: Gingers More Prone to Skin Cancer

Gingers More Prone to Skin Cancer

By | November 2, 2012

Researchers identify an unexpected molecular explanation for the higher incidence of skin cancer in redheads.

5 Comments

image: Contributors

Contributors

By | November 1, 2012

Meet some of the people featured in the November 2012 issue of The Scientist.

0 Comments

image: Omega-3s: Fishing for a Mechanism

Omega-3s: Fishing for a Mechanism

By | November 1, 2012

Despite abundant evidence supporting their ability to help prevent and treat cardiovascular disease, the therapeutic effectiveness of fish oil–derived fatty acids remains controversial.

4 Comments

image: The Road Less Traveled

The Road Less Traveled

By | November 1, 2012

First, Aravinda Chakravarti drew a map of how scientists might unravel the genetics of complex disease. Then he blazed the trail.

0 Comments

image: Tumor Snipers

Tumor Snipers

By | November 1, 2012

After two headline successes, companies rush to develop “smart bomb” cancer drugs.

0 Comments

Popular Now

  1. UC Berkeley Receives CRISPR Patent in Europe
    Daily News UC Berkeley Receives CRISPR Patent in Europe

    The European Patent Office will grant patent rights over the use of CRISPR in all cell types to a University of California team, contrasting with a recent decision in the U.S.

  2. DNA Replication Errors Contribute to Cancer Risk
  3. Should Healthy People Have Their Exomes Sequenced?
    Daily News Should Healthy People Have Their Exomes Sequenced?

    With its announced launch of a whole-exome sequencing service for apparently healthy individuals, Ambry Genetics is the latest company to enter this growing market. But whether these services are useful for most people remains up for debate.  

  4. Rethinking a Cancer Drug Target
    Daily News Rethinking a Cancer Drug Target

    The results of a CRISPR-Cas9 study suggest that MELK—a protein thought to play a critical role in cancer—is not necessary for cancer cell survival.

Business Birmingham